SCHEMBL19902690

SCHEMBL19902690

CC(C)C(=O)N[C@H]1CC[C@H](c2n[nH]c(=O)c3ccccc32)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.44
CYP1A2 P05177 2/20 0.44
ROCK2 O75116 4/20 0.44
ROCK1 Q13464 3/20 0.44
POLB P06746 1/20 0.43
PARP1 P09874 1/20 0.43
ALDH1A1 P00352 2/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
HTT P42858 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
BTK Q06187 1/20 0.40
DRD2 P14416 1/20 0.40
HTR2A P28223 1/20 0.40
DRD3 P35462 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17452766 0.85 ROCK2 (0.59) SMN1; SMN2CYP1A2ROCK2ROCK1POLB
SCHEMBL19902689 0.84 ROCK2 (0.46) SMN1; SMN2CYP1A2ROCK2ROCK1ALDH1A1
SCHEMBL19902452 0.83 SMN1; SMN2 (0.45) SMN1; SMN2CYP1A2ROCK2ROCK1POLB
SCHEMBL19902393 0.81 ROCK2 (0.41) SMN1; SMN2CYP1A2ROCK2ROCK1POLB
SCHEMBL19902295 0.81 JAK1 (0.49) CYP1A2ROCK2ROCK1PARP1ALDH1A1
SCHEMBL19902293 0.81 JAK1 (0.49) CYP1A2ROCK2ROCK1PARP1ALDH1A1
SCHEMBL19902296 0.81 JAK1 (0.49) CYP1A2ROCK2ROCK1PARP1ALDH1A1
SCHEMBL1789261 0.80 ATM (0.50) ROCK2ROCK1POLBPARP1ALDH1A1
SCHEMBL19902318 0.80 ROCK1 (0.55) CYP1A2ROCK2ROCK1PARP1ALDH1A1
SCHEMBL19902546 0.78 ROCK2 (0.61) ROCK2ROCK1POLBNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9902702-B2 Spirocycloheptanes as inhibitors of rock BRISTOL-MYERS SQUIBB COMPANY (US) 2018-02-27 US disclosed